InvestSMART

Proteomics International Laboratories Ltd (ASX: PIQ) - Announcements

Current share price for PIQ : $0.120 0.003 (2.13%)+

ASX company news and announcements for Proteomics International Laboratories Ltd (PIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Proteomics International Laboratories Ltd (PIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Proteomics International Laboratories Ltd (PIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Proteomics International Laboratories Ltd (PIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$20 Change of Director's Interest Notice x3 26 Nov 2025 8:32AM $0.335 $0.120 fallen by 64.18%
$20 Notification of cessation of securities - PIQ 26 Nov 2025 8:29AM $0.335 $0.120 fallen by 64.18%
$20 OxiDx test correlates with superior racehorse performance 24 Nov 2025 8:37AM $0.325 $0.120 fallen by 63.08%
$20 Results of Meeting 21 Nov 2025 2:46PM $0.320 $0.120 fallen by 62.50%
$20 AGM Chair's Address and Company Presentation 21 Nov 2025 11:51AM $0.325 $0.120 fallen by 63.08%
$20 Investor presentation - Bell Potter Healthcare Conference 18 Nov 2025 10:55AM $0.340 $0.120 fallen by 64.71%
$20 Proteomics International receives $2.2m in R&D tax incentive 12 Nov 2025 9:04AM $0.345 $0.120 fallen by 65.22%
$20 PromarkerEndo test for endometriosis receives $0.5m grant 6 Nov 2025 1:51PM $0.330 $0.120 fallen by 63.64%
$20 Quarterly Activities/Appendix 4C Cash Flow Report 27 Oct 2025 9:50AM $0.350 $0.120 fallen by 65.71%
$20 Notice of Annual General Meeting/Proxy Form 22 Oct 2025 2:21PM $0.350 $0.120 fallen by 65.71%
$20 Initial Directors Interest Notice 15 Oct 2025 11:00AM $0.400 $0.120 fallen by 70%
$20 Collaboration expanded to advance Endometriosis blood test 15 Oct 2025 8:33AM $0.390 $0.120 fallen by 69.23%
$20 Appointment of Director 14 Oct 2025 9:02AM $0.365 $0.120 fallen by 67.12%
$20 Notification regarding unquoted securities - PIQ 13 Oct 2025 11:51AM $0.360 $0.120 fallen by 66.67%
$20 Proposed issue of securities - PIQ 10 Oct 2025 8:24AM $0.375 $0.120 fallen by 68%
$20 Appointment of Company Secretary 7 Oct 2025 8:31AM $0.390 $0.120 fallen by 69.23%
$20 Notification of cessation of securities - PIQ 1 Oct 2025 10:59AM $0.350 $0.120 fallen by 65.71%
$20 Notification regarding unquoted securities - PIQ 1 Oct 2025 10:58AM $0.350 $0.120 fallen by 65.71%
$20 Esophageal cancer test results presented at World Congress 19 Sep 2025 8:38AM $0.335 $0.120 fallen by 64.18%
$20 Proteomics granted certification for Diagnostics Laboratory 18 Sep 2025 8:26AM $0.290 $0.120 fallen by 58.62%
$20 Notice of AGM Date 16 Sep 2025 3:36PM $0.295 $0.120 fallen by 59.32%
$20 Board and Management Transition 9 Sep 2025 8:53AM $0.320 $0.120 fallen by 62.50%
$20 PromarkerEso precisely detects early stage esophageal cancer 8 Sep 2025 8:36AM $0.305 $0.120 fallen by 60.66%
$20 Annual Report to Shareholders 27 Aug 2025 9:12AM $0.320 $0.120 fallen by 62.50%
$20 Appendix 4G and Corporate Governance Statement 27 Aug 2025 9:06AM $0.320 $0.120 fallen by 62.50%

51 - 75 of 702 results

Page 3 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.